NHERF1 Enhances Cisplatin Sensitivity in Human Cervical Cancer Cells

Cervical cancer is one of the most common female malignancies, and cisplatin-based chemotherapy is routinely utilized in locally advanced cervical cancer patients. However, resistance has been the major limitation. In this study, we found that Na(+)/H(+) Exchanger Regulatory Factor 1 (NHERF1) was do...

Descripción completa

Detalles Bibliográficos
Autores principales: Tao, Tao, Yang, Xiaomei, Qin, Qiong, Shi, Wen, Wang, Qiqi, Yang, Ying, He, Junqi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5297640/
https://www.ncbi.nlm.nih.gov/pubmed/28085111
http://dx.doi.org/10.3390/ijms18010005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5297640/
https://www.ncbi.nlm.nih.gov/pubmed/28085111
http://dx.doi.org/10.3390/ijms18010005

Ejemplares similares